Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation

This publication has 20 references indexed in Scilit:

• Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial
  The Lancet Respiratory Medicine, 2018
• The role of total cell-free DNA in predicting outcomes among trauma patients in the intensive care unit: a systematic review
  Critical Care, 2017
• Organ donation and transplantation: An updated overview
  MAMC Journal of Medical Sciences, 2016
• Impact of CLAD Phenotype on Survival After Lung Retransplantation: A Multicenter Study
  American Journal of Transplantation, 2015
• An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome
  European Respiratory Journal, 2014
• Respiratory infections in patients with cystic fibrosis undergoing lung transplantation
  The Lancet Respiratory Medicine, 2014
• Interobserver Variability in Grading Transbronchial Lung Biopsy Specimens After Lung Transplantation
  Chest, 2013
• Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
  American Journal of Respiratory and Critical Care Medicine, 2013
• Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation
  The Journal of Heart and Lung Transplantation, 2010
• Course of FEV1 after Onset of Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients
  American Journal of Respiratory and Critical Care Medicine, 2007